Intelligent Bio Solutions Reports 98.2% Accuracy in Drug Testing
NEW YORK, September 2, 2026 Intelligent Bio Solutions Inc. has reported strong performance results for its Intelligent Fingerprinting Drug...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NEW YORK, September 2, 2026 Intelligent Bio Solutions Inc. has reported strong performance results for its Intelligent Fingerprinting Drug...
New York, August 3, 2026 Intelligent Bio Solutions Inc. (INBS) announced the completion of an Interference Study for its...
NEW YORK, July 21, 2026 Intelligent Bio Solutions Inc. announced the successful completion of precision testing, an important milestone...
VANCOUVER, British Columbia, July 8, 2026 Cannabix Technologies Inc. and Omega Laboratories announced the development and validation of a...
NEW YORK, June 16, 2026 Intelligent Bio Solutions (INBS) announced the initiation of a critical clinical Interference Study designed...
